Atom Investors’s Pfizer PFE Stock Holding History

Atom Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	56,935 -119,320	-68%	-$3.12M	0.12%	267
2026 Q1	$4.95M	Buy	176,255 +8,984	+5%	+$239K	0.35%	82
2025 Q4	$4.17M	Buy	167,271 +118,463	+243%	+$2.99M	0.33%	98
2025 Q3	$1.24M	Sell	48,808 -64,536	-57%	-$1.59M	0.09%	221
2025 Q2	$2.75M	Buy	+113,344	New	+$2.64M	0.24%	118
2023 Q4	–	Sell	-58,838	Closed	-$1.95M	–	527
2023 Q3	$1.95M	Buy	58,838 +27,025	+85%	+$956K	0.45%	50
2023 Q2	$1.17M	Buy	+31,813	New	+$1.24M	0.44%	50
2019 Q2	–	Sell	-54,235	Closed	-$2.19M	–	571
2019 Q1	$2.19M	Buy	+54,235	New	+$2.17M	0.18%	128

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Atom Investors's PFE Position: Q2 2026 in Review

Atom Investors reduced its Pfizer (PFE) stake by 68% in Q2 2026, selling an estimated $3.12M and leaving 56,935 shares worth $1.37M. The position accounts for 0.12% of the portfolio, ranked #267.

Atom Investors first reported a position in PFE in Q1 2019 and has held it in 8 quarters since. The position peaked at $4.95M in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Atom Investors held 56,935 shares of Pfizer worth $1.37M as of Q2 2026.
Atom Investors sold 119,320 Pfizer shares in Q2 2026, an estimated $3.12M.
Pfizer made up 0.12% of Atom Investors's portfolio in Q2 2026, its #267 holding.
Atom Investors first reported a position in Pfizer in Q1 2019 and has held it in 8 quarters since.
Atom Investors's Pfizer position peaked at $4.95M in Q1 2026.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.